Levetiracetam is a widely used antiseizure medication sold under the brand name
Keppra and as numerous generic products. It can help control several types of
seizures, comes in immediate-release and extended-release forms, and has fewer
metabolism-based drug interactions than many older antiseizure medicines.
That does not make it a “set it and forget it” pill, however. Drowsiness,
dizziness, irritability, mood changes, kidney function, and rare but serious
reactions all deserve attention. Here is what patients and caregivers should
know without needing a decoder ring for the prescription label.
What are levetiracetam oral tablets?
Levetiracetam belongs to a group of medicines called anticonvulsants, also
known as antiseizure medications. Immediate-release tablets are commonly
available in 250-mg, 500-mg, 750-mg, and 1,000-mg strengths and are usually
taken twice daily.
Extended-release levetiracetam is generally taken once daily and has different
approved uses and age limits. The products may share an active ingredient,
but their release patterns are not identical, so swapping one for another
without instructions is a bad sequel nobody ordered.
How levetiracetam works
The exact way levetiracetam prevents seizures is not fully understood. Its
best-known action is binding to synaptic vesicle protein 2A, or SV2A, a protein
involved in the release of chemical messengers between nerve cells.
In practical terms, the medicine helps reduce overly synchronized electrical
activity that can produce seizures. Think of it as helping the brain’s
electrical orchestra stay on tempo instead of letting every instrument launch
into an unexpected solo.
What is levetiracetam used for?
Partial-onset seizures
Levetiracetam is approved to treat partial-onset seizures, now commonly called
focal-onset seizures, in patients 1 month of age and older. These seizures
begin in one area of the brain, although they may spread to involve both sides.
Depending on the patient’s age and clinical situation, levetiracetam may be
prescribed alone or alongside another antiseizure medicine.
Myoclonic seizures
For people 12 years and older with juvenile myoclonic epilepsy, levetiracetam
is approved as add-on therapy for myoclonic seizures. These seizures often
appear as quick, shock-like muscle jerks.
Dropping a toothbrush one morning may be ordinary clumsiness. Repeated sudden
jerks in a recognizable pattern deserve medical evaluation.
Primary generalized tonic-clonic seizures
Levetiracetam is also approved as adjunctive treatment for primary generalized
tonic-clonic seizures in people 6 years and older with idiopathic generalized
epilepsy.
These seizures involve both sides of the brain from the start and may cause
muscle stiffening, rhythmic jerking, loss of consciousness, and a recovery
period afterward.
Off-label uses
Clinicians sometimes use levetiracetam off-label in selected hospital,
emergency, neurosurgical, or palliative-care settings. An off-label use is
not a do-it-yourself invitation. The reason for treatment, dosage, and
duration must be determined by the treating medical team.
Levetiracetam dosage
The correct levetiracetam dosage depends on seizure type, age, body weight,
kidney function, dosage form, other medicines, seizure control, and side
effects. The figures below summarize common U.S. label-based dosing for
immediate-release products and are not a personalized prescription.
Typical adult dosage for partial-onset seizures
For adults 16 years and older, treatment commonly begins with 500 mg twice
daily, for a total of 1,000 mg per day. The prescriber may increase the total
daily dose by 1,000 mg every two weeks.
The maximum recommended dosage is 3,000 mg per day, usually divided as
1,500 mg twice daily. The prescribing information states that doses above
3,000 mg per day have not demonstrated additional benefit for partial-onset
seizures.
Dosage for myoclonic seizures
For patients 12 years and older with juvenile myoclonic epilepsy, the usual
starting dosage is 500 mg twice daily. It may be increased by 1,000 mg per
day every two weeks to the recommended dosage of 3,000 mg per day.
Dosage for generalized tonic-clonic seizures
Adults 16 years and older generally begin with 500 mg twice daily. The dosage
may be increased every two weeks to 1,500 mg twice daily when clinically
appropriate.
Pediatric dosage
Children are not simply small adults wearing superhero socks. Pediatric
dosing may be based on age and body weight, and an oral liquid may be preferred
when tablets cannot provide an accurate dose.
For several pediatric indications, treatment starts at approximately
10 mg per kilogram of body weight twice daily and may be increased every
two weeks, often to a target of 30 mg per kilogram twice daily. Infants and
younger children have separate instructions.
Liquid doses should be measured with a calibrated oral syringe or another
approved measuring device. A kitchen teaspoon is great for soup and
spectacularly unqualified for precision medication dosing.
Kidney-based dosage adjustments
Levetiracetam is cleared largely through the kidneys. For immediate-release
dosing in adults, recommended ranges are adjusted according to creatinine
clearance.
| Kidney function | Creatinine clearance | Immediate-release dosage range |
|---|---|---|
| Normal | Above 80 mL/min/1.73 m² | 500 to 1,500 mg every 12 hours |
| Mild impairment | 50 to 80 mL/min/1.73 m² | 500 to 1,000 mg every 12 hours |
| Moderate impairment | 30 to 50 mL/min/1.73 m² | 250 to 750 mg every 12 hours |
| Severe impairment | Below 30 mL/min/1.73 m² | 250 to 500 mg every 12 hours |
| End-stage kidney disease with dialysis | Individualized | 500 to 1,000 mg every 24 hours, plus 250 to 500 mg after dialysis |
These ranges still require an individualized prescription. Older adults may
need closer kidney monitoring because kidney function often declines with age,
even when everything else insists it is still young at heart.
How to take levetiracetam tablets safely
Take levetiracetam at consistent times each day, with or without food.
Immediate-release tablets are generally taken twice daily, while
extended-release tablets are commonly taken once daily.
Swallow the tablets according to the instructions for your exact product.
Extended-release tablets should not be crushed or chewed. Some
immediate-release products are scored, but splitting should occur only when
the product instructions, pharmacist, or prescriber confirms that it is
appropriate.
What to do after a missed dose
Take a missed dose when remembered unless it is almost time for the next
scheduled dose. In that situation, skip the missed dose and continue the
regular schedule. Do not take a double or extra dose.
Phone alarms, medication apps, pill organizers, and linking doses to reliable
daily routines can help. Consistency matters because missed antiseizure
medicine can increase the risk of a breakthrough seizure.
Do not stop levetiracetam suddenly
Abrupt withdrawal can increase seizure frequency and may contribute to status
epilepticus, a prolonged seizure or series of seizures without adequate
recovery. When stopping treatment is appropriate, clinicians normally reduce
the dosage gradually.
Rapid discontinuation may occasionally be required after a serious allergic
or other dangerous reaction, but that decision should be made by medical
professionals.
Common levetiracetam side effects
Frequently reported side effects include:
- Sleepiness or excessive tiredness
- Fatigue or weakness
- Dizziness
- Headache
- Irritability
- Reduced appetite
- Unsteady walking or coordination problems
- Nausea, vomiting, diarrhea, or constipation
- Double vision
- Neck or joint pain
In adult trials involving partial-onset seizures, sleepiness and weakness each
occurred in approximately 15% of levetiracetam-treated patients. Dizziness
occurred in about 9%. Sleepiness and fatigue were most noticeable during the
first four weeks of treatment.
That early adjustment period can feel like the brain has switched to
battery-saver mode. Mild effects may improve, but persistent, severe, or
disruptive symptoms should be reported rather than silently endured.
Mood and behavior changes
Levetiracetam deserves particular attention for possible behavioral and
psychiatric side effects. These may include:
- Irritability or anger
- Aggression or hostility
- Agitation or restlessness
- Anxiety or panic symptoms
- Depression
- Emotional instability
- Confusion or hallucinations
- Rare psychotic symptoms
In controlled studies, nonpsychotic behavioral symptoms were reported more
frequently with levetiracetam than with placebo in both adults and children.
Young patients may be particularly vulnerable to irritability or aggressive
behavior.
Family members and caregivers sometimes notice a personality or mood shift
before the person taking the medicine recognizes it. New rage, dangerous
impulsivity, social withdrawal, worsening depression, panic attacks, or
“this is not me” behavior should prompt contact with the prescriber.
Antiseizure medicines, including levetiracetam, carry a warning about suicidal
thoughts and behavior. Seek urgent professional help for suicidal thoughts,
self-harm behavior, or an immediate risk of harm.
Serious side effects requiring urgent attention
Contact a healthcare professional promptly or obtain emergency care for:
- A rash, blistering, skin peeling, mouth sores, or fever occurring with a rash
-
Facial, lip, tongue, eye, or throat swelling; hives; breathing difficulty;
or trouble swallowing -
Fever, swollen lymph nodes, facial swelling, dark urine, yellow skin or
eyes, or unusual exhaustion - Severe loss of coordination or difficulty walking
- Extreme sedation, fainting, or reduced consciousness
- Unusual bruising, bleeding, recurrent infections, or marked weakness
- Seizures that become more frequent, longer, or different
DRESS and serious skin reactions
Drug Reaction with Eosinophilia and Systemic Symptoms, known as DRESS, is a
rare but potentially life-threatening hypersensitivity reaction. It may begin
with a rash, fever, facial swelling, or swollen lymph nodes and can progress
to injury involving the liver, kidneys, heart, blood, muscles, or other organs.
Early DRESS symptoms can occur even without an obvious rash. The FDA added a
specific warning because prompt diagnosis and treatment are important.
Stevens-Johnson syndrome and toxic epidermal necrolysis have also been reported.
A new rash should not be casually “watched for a week to see what happens”
without medical advice.
Blood-cell abnormalities
Levetiracetam can occasionally affect white blood cells, red blood cells,
platelets, hemoglobin, or other blood measurements. A clinician may order a
complete blood count if a patient develops significant weakness, persistent
fever, recurrent infections, or abnormal bleeding.
Drug interactions, alcohol, and driving
Levetiracetam has relatively few pharmacokinetic interactions because it is
not heavily processed by liver cytochrome P450 enzymes and is minimally bound
to blood proteins.
Prescribing-information studies found no meaningful effect on several common
antiseizure medicines, warfarin, digoxin, or the studied combined oral
contraceptive. Nevertheless, every patient should give the prescriber and
pharmacist a complete medication list.
Alcohol and sedating substances
Alcohol, cannabis, opioids, sleeping medicines, sedating antihistamines, and
other central nervous system depressants may worsen sleepiness, dizziness,
slow reaction time, or poor coordination.
Do not drive, climb ladders, operate machinery, or swim alone until you know
how levetiracetam affects you. State driving rules for people who experience
seizures also apply independently of medication side effects.
Pregnancy, breastfeeding, and special populations
Pregnancy
Seizure control remains important during pregnancy, so levetiracetam should
not be stopped after a positive pregnancy test without medical guidance.
Blood levels may decrease during pregnancy, particularly later in pregnancy,
and clinicians may monitor medication concentrations and seizure frequency
more closely.
Available human data have not established an association between levetiracetam
use and major birth defects or miscarriage. However, no medicine can be
declared risk-free in every pregnancy, and the risks of uncontrolled seizures
must also be considered.
Pregnant patients may consider enrolling in the North American Antiepileptic
Drug Pregnancy Registry, which collects information about pregnancy outcomes
after exposure to antiseizure medicines.
Breastfeeding
Levetiracetam passes into breast milk. The decision to breastfeed should
consider the benefits of breastfeeding, the parent’s need for seizure
treatment, seizure-related safety, and potential effects such as excessive
sleepiness or feeding difficulty in the infant.
Older adults and kidney disease
People with kidney disease, older adults, and patients receiving dialysis
frequently need dosage adjustments. Kidney function may be checked before
treatment and periodically afterward.
Frequently asked questions about levetiracetam
Does levetiracetam cure epilepsy?
No. Levetiracetam helps control seizures while it is taken. Some people may
eventually taper antiseizure treatment after remaining seizure-free, but the
decision depends on seizure type, EEG findings, imaging, medical history, and
specialist judgment.
How quickly does levetiracetam work?
Immediate-release levetiracetam is absorbed quickly, with peak blood
concentrations generally reached in approximately one to two hours. Finding
the most effective dosage and judging long-term seizure control may still
take weeks or months.
Does levetiracetam cause weight gain?
Weight gain is not generally considered a leading levetiracetam side effect.
Reduced appetite may occur. Significant weight changes should be discussed
because diet, mood, seizures, other medicines, and unrelated medical
conditions may also contribute.
What happens after a levetiracetam overdose?
Reported overdose symptoms include marked drowsiness, agitation, aggression,
reduced consciousness, breathing difficulty, and coma.
In the United States, call Poison Control at 1-800-222-1222. Call 911
immediately if the person collapses, cannot be awakened, has difficulty
breathing, or experiences a seizure.
Experiences with levetiracetam: What treatment may feel like
The following are composite educational scenarios based on commonly reported
treatment patterns. They are not quotations from specific patients and do not
predict what any individual will experience.
The first few weeks may be the sleepiest
The first experience many people notice is not dramatic seizure control but
ordinary sleepiness. A person may begin taking 500 mg twice daily and spend
the first week wondering why the afternoon suddenly feels three hours longer.
Morning grogginess, mild dizziness, or a need for an earlier bedtime can occur
while the body adjusts. For some patients, these effects fade over several
weeks. For others, fatigue remains disruptive enough that the prescriber
changes the dosage, timing, release formulation, or medication plan.
A useful approach is documenting the pattern: when the dose was taken, when
fatigue appeared, and whether it interfered with work, school, balance,
exercise, childcare, or driving.
Mood changes can be subtle at first
Another commonly discussed experience involves mood. Someone who rarely
snapped at family members may become unusually impatient, angry, nervous, or
tearful after beginning treatment or increasing the dosage.
Because ordinary life is perfectly capable of causing irritability without
pharmaceutical assistance, the connection may initially be missed. A simple
daily mood log and honest observations from a partner, parent, friend, or
roommate may help reveal whether the change began around the same time as
treatment.
Sudden aggression, severe depression, dangerous impulsivity, or thoughts of
self-harm require urgent professional attention, not a motivational quote and
a cup of tea.
For some people, treatment becomes pleasantly uneventful
Other patients experience a much quieter adjustment: fewer seizures, no major
side effects, and a growing routine around one or two daily doses. They keep
tablets in a consistent location, use phone alarms, request refills early, and
carry medication when traveling.
Eventually, taking levetiracetam may become less of a daily event and more
like brushing teethimportant, repetitive, and ideally not something
remembered halfway through a road trip.
Breakthrough seizures do not always mean the medicine failed
A patient may be doing well, miss several doses during travel, sleep poorly,
develop an infection, and then experience a seizure. The lesson is not
automatically that levetiracetam failed. Adherence, sleep, illness, alcohol,
stress, and the underlying epilepsy can all affect seizure risk.
A seizure diary can help the neurologist distinguish a missed-dose problem
from a new seizure pattern, an inadequate dosage, or a need for additional
testing.
Dosage adjustments can involve tradeoffs
Increasing the dosage may improve seizure control while worsening fatigue or
irritability. Lowering it may improve mental clarity but allow more seizure
activity. Treatment therefore becomes a balance rather than a contest to
reach the largest number printed on the bottle.
The best dosage is an effective and tolerable dosage chosen for the individual,
not whatever worked for a stranger in an online forum.
Caregivers may notice changes first
Caregivers often monitor subtle staring episodes, morning muscle jerks,
sleepiness, falls, mood changes, or forgotten tablets. Helpful support should
be specific and respectful.
Saying, “You seem much more irritable since the dosage changed; can we call
the clinic?” is usually more useful than, “You are impossible on this
medicine.” The goal is shared observation, not surveillance or blame.
Side effects and seizure control should be discussed together
A medication that prevents seizures but severely harms mood may require
adjustment. A medication that causes mild early fatigue but provides strong
seizure control may become easier to tolerate with time.
Regular follow-up, accurate symptom notes, kidney monitoring when appropriate,
and prompt reporting of red-flag reactions can help turn levetiracetam from a
mysterious pill into a manageable part of an epilepsy care plan.
Conclusion
Levetiracetam oral tablets are a flexible and commonly prescribed treatment
for focal, myoclonic, and primary generalized tonic-clonic seizures.
Immediate-release treatment often begins at 500 mg twice daily in adults and
is adjusted gradually, while children and people with impaired kidney function
require individualized dosing.
Common levetiracetam side effects include sleepiness, fatigue, dizziness, and
irritability. Mood changes, serious rashes, DRESS, allergic swelling, blood
abnormalities, worsening seizures, and suicidal thoughts require prompt
attention.
The practical rules are refreshingly unglamorous: take doses consistently,
do not double a missed dose, avoid abrupt withdrawal, monitor seizure and mood
changes, and keep the prescribing team informed. In epilepsy treatment,
boring routines are often the unsung superheroes.